| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71335-2264-1 | 71335-2264 | HUMAN PRESCRIPTION DRUG | Cevimeline Hydrochloride | Cevimeline Hydrochloride | CAPSULE | ORAL | 20231027 | N/A | ANDA | ANDA091591 | Bryant Ranch Prepack | CEVIMELINE HYDROCHLORIDE | 30 mg/1 | 30 CAPSULE in 1 BOTTLE (71335-2264-1) |
| 71335-2264-2 | 71335-2264 | HUMAN PRESCRIPTION DRUG | Cevimeline Hydrochloride | Cevimeline Hydrochloride | CAPSULE | ORAL | 20231027 | N/A | ANDA | ANDA091591 | Bryant Ranch Prepack | CEVIMELINE HYDROCHLORIDE | 30 mg/1 | 60 CAPSULE in 1 BOTTLE (71335-2264-2) |
| 71335-2264-3 | 71335-2264 | HUMAN PRESCRIPTION DRUG | Cevimeline Hydrochloride | Cevimeline Hydrochloride | CAPSULE | ORAL | 20231027 | N/A | ANDA | ANDA091591 | Bryant Ranch Prepack | CEVIMELINE HYDROCHLORIDE | 30 mg/1 | 90 CAPSULE in 1 BOTTLE (71335-2264-3) |
| 0054-0334-25 | 0054-0334 | HUMAN PRESCRIPTION DRUG | Cevimeline Hydrochloride | Cevimeline Hydrochloride | CAPSULE | ORAL | 20130708 | N/A | ANDA | ANDA091591 | Hikma Pharmaceuticals USA Inc. | CEVIMELINE HYDROCHLORIDE | 30 mg/1 | 100 CAPSULE in 1 BOTTLE (0054-0334-25) |